News

GSK announced that it agreed to settle these suits for up to $2.2 billion, in a press release on Wednesday. GSK says that ...
GSK has reached ... outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has agreed to pay $2.2 billion to settle around ...
The three-day hearing comes a few months after GSK decided to settle a complaint brought ... The common claim in the lawsuits is that a contaminant in Zantac (ranitidine) called N ...